Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,921,010 papers from all fields of science
Search
Sign In
Create Free Account
(trifluoromethyl)phenyldiazirinylfenpyroximate
Known as:
TDF cpd
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Benzoates
Pyrazoles
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial
H. Yim
,
Won Kim
,
+21 authors
K. Han
American Journal of Gastroenterology
2020
Corpus ID: 218470931
INTRODUCTION: Chronic hepatitis B (CHB) remains a major worldwide public health concern. Besifovir dipivoxil maleate (BSV) is a…
Expand
2019
2019
Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
Xieer Liang
,
Zhiliang Gao
,
+23 authors
J. Hou
Hepatology International
2019
Corpus ID: 109939498
Background and aimLong-term treatment with tenofovir disoproxil fumarate (TDF) has demonstrated suppression of viral replication…
Expand
2018
2018
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection.
S. Ahn
,
Won Kim
,
+25 authors
K. Han
Clinical Gastroenterology and Hepatology
2018
Corpus ID: 53952429
2018
2018
Natural History and Ecology of Soldier Beetles (Coleoptera: Cantharidae) in the Mexican Tropical Dry Forests
Cisteil X. Pérez-Hernández
Environmental Entomology
2018
Corpus ID: 3625732
Abstract Until today, most information about the natural history and ecology of soldier beetles came from temperate zones, mainly…
Expand
2017
2017
Monotherapy with tenofovir disoproxil fumarate for multiple drug‐resistant chronic hepatitis B: 3‐year trial
Y. Lim
,
Y. Lee
,
+7 authors
S. Kwon
Hepatology
2017
Corpus ID: 205904853
Combination therapy has been recommended for the treatment of patients harboring multiple drug‐resistant hepatitis B virus (HBV…
Expand
2017
2017
Fibrous Cellular Structures are Found in a Commercial Fruit Smoothie and Remain Intact during Simulated Digestion
Jin Chu
,
B. D. Igbetar
,
C. Orfila
2017
Corpus ID: 53349719
The intactness of cell wall structures in foods has important repercussions for nutrient digestion and availability. In this…
Expand
2016
2016
All-fiber high-average power nanosecond-pulsed master-oscillator power amplifier at 2 μm with mJ-level pulse energy.
Xiongfei Wang
,
Xiaoxi Jin
,
P. Zhou
,
Xiao-lin Wang
,
H. Xiao
,
Zejin Liu
Applied Optics
2016
Corpus ID: 22876774
We present a high-power nanosecond-pulsed Tm-doped fiber amplifier at 1.971 μm based on a master-oscillator power amplifier (MOPA…
Expand
Highly Cited
2015
Highly Cited
2015
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial
Y. Lim
,
B. Yoo
,
+5 authors
Y. Lee
Gut
2015
Corpus ID: 3465243
Objective Little clinical data are available regarding the optimal treatment of patients who harbour adefovir-resistant HBV…
Expand
2012
2012
Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes.
L. Elzi
,
S. Erb
,
+7 authors
M. Battegay
Archives of Internal Medicine
2012
Corpus ID: 18091026
BACKGROUND Current guidelines give recommendations for preferred combination antiretroviral therapy (cART). We investigated…
Expand
2008
2008
Papel actual de tenofovir en la clínica
E. R. Pascuet
,
A. Curran
2008
Corpus ID: 74175630
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE